Drug Type Proteolysis-targeting chimeras (PROTAC) |
Synonyms PHOTAC-I-13 |
Target |
Action inhibitors, degraders |
Mechanism BRD2 inhibitors(Bromodomain-containing protein 2 inhibitors), BRD3 inhibitors(Bromodomain-containing protein 3 inhibitors), BRD4 degraders(Bromodomain-containing protein 4 degraders) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC48H39ClN10O7S |
InChIKeyLZTPVXATJDYENS-LTDQXGDMSA-N |
CAS Registry- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | United States | 21 Feb 2020 | |
Neoplasms | Preclinical | Germany | 21 Feb 2020 |